Rapid antigen testing has been used extensively overseas for some time and could soon become a more prevalent tool in Australia's management of COVID-19.
The federal government's announcement of supply agreements with Novavax and Pfizer potentially increases the pool of COVID-19 vaccines Australians will be able to access.
